Alkem's Enzene powers into US with $70 m investment

Enzene Biosciences, an Alkem Labs subsidiary, has inaugurated a new US manufacturing plant. The facility is located in New Jersey. This venture represents a $70 million investment. It aligns with calls to boost local pharma manufacturing. Enzene's technology offers cost-effective drug production. The company currently employs 50 people. Enzene plans to increase its workforce to 200.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FW6hpHG
via IFTTT